News search
Research 5 Jan 2022 Scientists at the CNIC have developed a simple model for studying the behavior of immune cells in live animals and have identified a harmful cell behavior pattern associated with cardiovascular disease |
Research 26 Oct 2021 Scientists from the CNIC and the CIBERCV have generated the first experimental animal model that develops Hutchinson-Gilford Progeria Syndrome and allows its controlled reversal |
About the CNIC 6 Aug 2021 CNIC and the Mario Negri Institute in Milan (Italy) coordinate REBOOT, a project that aims to study whether treatment with beta-blockers is beneficial for patients who have suffered a myocardial infarction |
Research 21 Jul 2021 The research team led by project leader Dr Silvia Priori is confident that the discovery of new therapies will reduce the mortality linked to this disease and could also reduce arrhythmias in heart failure patients |
About the CNIC 17 Jun 2021 The jury acknowledged this CNIC researcher's contribution to understanding why obesity causes cardiometabolic diseases. |
About the CNIC 10 Jun 2021 The €35,000 awarded by the foundation in each category is for research that deepens knowledge of the relationship between nutrition, food and health |
About the CNIC 9 Jun 2021 The study, published in Nature in 2019, revealed relevant data about the involvement of the protein p38gamma in the development of the main type of primary liver cancer, which affects over a million people a year worldwide |
About the CNIC 8 Jun 2021 Dr Enríquez and Dr del Pozo Muñoz join their colleagues Dr Miguel Torres, Dr Pura Muñoz and Dr Francisco Sánchez Madrid, bringing to five the number of CNIC members in EMBO |
About the CNIC 10 May 2021 Dr. Torres is a member of the European Molecular Biology Organization (EMBO). Dr. Miguel Torres’s scientific research focuses on the regulation of embryonic development and the formation and regeneration of organs. |
- ‹ previous
- 3 of 17
- next ›